Danaher Co. (NYSE:DHR) Stock Holdings Lowered by Janney Capital Management LLC

Janney Capital Management LLC reduced its holdings in Danaher Co. (NYSE:DHR) by 2.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 36,666 shares of the conglomerate’s stock after selling 891 shares during the quarter. Janney Capital Management LLC’s holdings in Danaher were worth $9,156,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Alpine Global Management LLC purchased a new position in shares of Danaher in the third quarter worth approximately $1,489,000. Advisors Asset Management Inc. increased its position in shares of Danaher by 3.1% in the third quarter. Advisors Asset Management Inc. now owns 10,983 shares of the conglomerate’s stock worth $2,725,000 after acquiring an additional 331 shares in the last quarter. Evergreen Capital Management LLC increased its position in shares of Danaher by 23.1% in the third quarter. Evergreen Capital Management LLC now owns 4,126 shares of the conglomerate’s stock worth $1,024,000 after acquiring an additional 775 shares in the last quarter. Royal London Asset Management Ltd. increased its position in shares of Danaher by 7.0% in the third quarter. Royal London Asset Management Ltd. now owns 311,242 shares of the conglomerate’s stock worth $77,219,000 after acquiring an additional 20,395 shares in the last quarter. Finally, Baker Avenue Asset Management LP increased its position in shares of Danaher by 4.2% in the third quarter. Baker Avenue Asset Management LP now owns 11,639 shares of the conglomerate’s stock worth $2,888,000 after acquiring an additional 468 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research firms have recently weighed in on DHR. Barclays lifted their target price on shares of Danaher from $260.00 to $270.00 and gave the stock an “equal weight” rating in a research report on Wednesday, April 24th. Robert W. Baird upped their price objective on shares of Danaher from $259.00 to $271.00 and gave the company an “outperform” rating in a research note on Wednesday, April 24th. HSBC upgraded shares of Danaher from a “hold” rating to a “buy” rating and upped their price objective for the company from $250.00 to $280.00 in a research note on Wednesday, April 17th. TD Cowen upped their price objective on shares of Danaher from $280.00 to $290.00 and gave the company a “buy” rating in a research note on Wednesday, April 24th. Finally, StockNews.com lowered shares of Danaher from a “buy” rating to a “hold” rating in a research note on Tuesday, June 25th. Six analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $268.67.

Danaher Stock Performance

NYSE:DHR traded down $0.75 during midday trading on Friday, reaching $239.25. The stock had a trading volume of 3,932,293 shares, compared to its average volume of 3,355,452. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.85 and a quick ratio of 1.51. Danaher Co. has a 1-year low of $182.09 and a 1-year high of $269.11. The firm’s fifty day simple moving average is $255.41 and its 200-day simple moving average is $246.95. The stock has a market capitalization of $177.21 billion, a P/E ratio of 40.55, a PEG ratio of 3.67 and a beta of 0.83.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share for the quarter, beating analysts’ consensus estimates of $1.72 by $0.20. Danaher had a net margin of 16.78% and a return on equity of 11.43%. The firm had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.62 billion. During the same period in the prior year, the firm earned $2.36 EPS. The business’s revenue was down 2.6% on a year-over-year basis. On average, equities research analysts forecast that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be issued a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a yield of 0.45%. The ex-dividend date of this dividend is Friday, June 28th. Danaher’s dividend payout ratio (DPR) is presently 18.31%.

Insider Buying and Selling at Danaher

In other news, Director Alan G. Spoon sold 708 shares of the firm’s stock in a transaction dated Thursday, May 2nd. The shares were sold at an average price of $243.58, for a total transaction of $172,454.64. Following the completion of the transaction, the director now directly owns 116,202 shares of the company’s stock, valued at approximately $28,304,483.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, Director Alan G. Spoon sold 708 shares of the firm’s stock in a transaction dated Thursday, May 2nd. The shares were sold at an average price of $243.58, for a total transaction of $172,454.64. Following the completion of the transaction, the director now directly owns 116,202 shares of the company’s stock, valued at approximately $28,304,483.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Brian W. Ellis sold 4,000 shares of the firm’s stock in a transaction dated Wednesday, April 24th. The stock was sold at an average price of $250.01, for a total transaction of $1,000,040.00. Following the transaction, the senior vice president now directly owns 29,830 shares of the company’s stock, valued at $7,457,798.30. The disclosure for this sale can be found here. Insiders sold a total of 148,783 shares of company stock valued at $37,536,717 in the last ninety days. Company insiders own 10.90% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.